Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for AUPH

Stock NameAurinia Pharmaceuticals Inc
TickerAUPH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINCA05156V1022

Show aggregate AUPH holdings

News associated with AUPH

7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?
(RTTNews) - Patience is a virtue - important in all aspects of life, and especially crucial when it comes to investing. As trading expert Steve Burns once said, "Much of our trading comes down to a battle between our patience and our impulses." - 2025-09-15 03:55:16
Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High on Analyst Upgrade
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH – Get Free Report) (TSE:AUP)’s stock price reached a new 52-week high during mid-day trading on Monday after Royal Bank Of Canada raised their price target on the stock from $8.00 to $9.00. Royal Bank Of Canada currently has an outperform rating on the stock. Aurinia Pharmaceuticals traded as high as […] - 2025-08-05 02:22:49
Aurinia Pharmaceuticals (NASDAQ:AUPH) Price Target Raised to $9.00
Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) had its price target upped by Royal Bank Of Canada from $8.00 to $9.00 in a report released on Friday,Benzinga reports. The brokerage currently has an outperform rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $17.00 price target on shares […] - 2025-08-04 04:59:02
Xponance Inc. Acquires New Position in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Xponance Inc. acquired a new stake in shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH – Free Report) (TSE:AUP) during the 1st quarter, Holdings Channel reports. The fund acquired 10,146 shares of the biotechnology company’s stock, valued at approximately $82,000. Several other institutional investors and hedge funds have also modified their holdings of the company. Tang Capital […] - 2025-07-21 05:02:57
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Passes Below 200 Day Moving Average – Should You Sell?
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH – Get Free Report) (TSE:AUP)’s stock price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $8.22 and traded as low as $7.81. Aurinia Pharmaceuticals shares last traded at $7.92, with a volume of 1,048,653 shares traded. […] - 2025-06-20 05:11:03
Bank of America Corp DE Has $574,000 Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Bank of America Corp DE decreased its stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 63.4% in the fourth quarter, HoldingsChannel reports. The firm owned 63,975 shares of the biotechnology company’s stock after selling 110,715 shares during the period. Bank of America Corp DE’s holdings in Aurinia Pharmaceuticals were worth $574,000 at […] - 2025-06-11 04:44:43
ProShare Advisors LLC Boosts Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
ProShare Advisors LLC lifted its stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 31.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 44,588 shares of the biotechnology company’s stock after purchasing an additional 10,771 shares during the period. ProShare Advisors LLC’s holdings in Aurinia Pharmaceuticals were worth $400,000 as of […] - 2025-05-28 06:22:59
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock Position Raised by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 3.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 76,314 shares of the biotechnology company’s stock after purchasing an additional 2,887 shares during the period. MIRAE ASSET […] - 2025-05-28 04:52:53
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Bought by Nuveen Asset Management LLC
Nuveen Asset Management LLC boosted its holdings in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,492,301 shares of the biotechnology company’s stock after buying an additional 138,054 […] - 2025-05-27 05:16:53
Graham Capital Management L.P. Makes New Investment in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Graham Capital Management L.P. acquired a new position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) in the 4th quarter, HoldingsChannel reports. The firm acquired 11,409 shares of the biotechnology company’s stock, valued at approximately $102,000. Other large investors also recently bought and sold shares of the company. SBI Securities Co. Ltd. […] - 2025-05-20 06:15:10
Gotham Asset Management LLC Has $404,000 Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Gotham Asset Management LLC boosted its holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 8.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 44,996 shares of the biotechnology company’s stock after buying an additional 3,655 shares during the period. Gotham […] - 2025-05-20 05:38:53
Notable Two Hundred Day Moving Average Cross - AUPH
In trading on Wednesday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) crossed below their 200 day moving average of $7.71, changing hands as low as $7.47 per share. Aurinia Pharmaceuticals Inc shares are currently trading down about 2.6% on the day. The chart below sho - 2025-05-14 12:56:31
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Position Lifted by Hsbc Holdings PLC
Hsbc Holdings PLC raised its stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 48.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 15,616 shares of the biotechnology company’s stock after acquiring an additional 5,080 shares during the period. Hsbc Holdings PLC’s holdings in Aurinia Pharmaceuticals were worth $141,000 as of […] - 2025-05-12 04:56:51
Barclays PLC Has $2.19 Million Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Barclays PLC raised its position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 11.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 243,948 shares of the biotechnology company’s stock after purchasing an additional 24,617 shares during the quarter. Barclays PLC’s holdings in Aurinia Pharmaceuticals were worth $2,190,000 at the end […] - 2025-05-02 06:02:58
Renaissance Technologies LLC Boosts Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Renaissance Technologies LLC boosted its position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 44.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 700,900 shares of the biotechnology company’s stock after purchasing an additional 214,200 shares during the quarter. Renaissance Technologies LLC […] - 2025-04-20 05:00:52
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Purchased by Federated Hermes Inc.
Federated Hermes Inc. grew its holdings in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 1,233,875.0% during the fourth quarter, Holdings Channel reports. The firm owned 49,359 shares of the biotechnology company’s stock after acquiring an additional 49,355 shares during the quarter. Federated Hermes Inc.’s holdings in Aurinia Pharmaceuticals were worth $443,000 […] - 2025-04-18 04:57:07
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Acquired by Franklin Resources Inc.
Franklin Resources Inc. increased its stake in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 358.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 92,921 shares of the biotechnology company’s stock after purchasing an additional 72,668 shares during […] - 2025-04-16 05:11:01
Wellington Management Group LLP Invests $546,000 in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Wellington Management Group LLP purchased a new stake in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 60,751 shares of the biotechnology company’s stock, valued at approximately $546,000. Other large investors also recently added […] - 2025-04-15 04:50:51
ExodusPoint Capital Management LP Takes Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
ExodusPoint Capital Management LP purchased a new position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 53,500 shares of the biotechnology company’s stock, valued at approximately $480,000. Several other hedge funds and other institutional investors have also bought and sold shares […] - 2025-04-13 05:33:20
How The Pieces Add Up: FHLC Targets $82
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-09 07:49:23
Teacher Retirement System of Texas Buys 2,020 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Teacher Retirement System of Texas increased its stake in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 5.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,098 shares of the biotechnology company’s stock after buying an additional […] - 2025-04-02 05:16:55
Aurinia Pharmaceuticals (NASDAQ:AUPH) versus Entrada Therapeutics (NASDAQ:TRDA) Head-To-Head Comparison
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) and Entrada Therapeutics (NASDAQ:TRDA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, earnings, dividends and risk. Institutional & Insider Ownership 36.8% of Aurinia […] - 2025-04-01 02:40:45
Swiss National Bank Sells 26,200 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Swiss National Bank decreased its holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 9.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 239,000 shares of the biotechnology company’s stock after selling 26,200 shares during the period. Swiss National Bank’s holdings in […] - 2025-03-28 07:44:57

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc AUPH holdings

DateNumber of AUPH Shares HeldBase Market Value of AUPH SharesLocal Market Value of AUPH SharesChange in AUPH Shares HeldChange in AUPH Base ValueCurrent Price per AUPH Share HeldPrevious Price per AUPH Share Held
2025-09-26 (Friday)16,309USD 214,300USD 214,300
2025-09-25 (Thursday)16,309USD 209,571AUPH holding decreased by -489USD 209,5710USD -489 USD 12.85 USD 12.88
2025-09-24 (Wednesday)16,309USD 210,060USD 210,060
2025-09-17 (Wednesday)16,205USD 199,322AUPH holding decreased by -3565USD 199,3220USD -3,565 USD 12.3 USD 12.52
2025-09-16 (Tuesday)16,205USD 202,887USD 202,887
2025-09-12 (Friday)16,101USD 205,127USD 205,127
2025-09-11 (Thursday)16,101AUPH holding increased by 208USD 205,771AUPH holding increased by 10287USD 205,771208USD 10,287 USD 12.78 USD 12.3
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AUPH by Blackrock for IE00B3VWM098

Show aggregate share trades of AUPH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-11BUY208 12.780* 8.18
2025-08-21SELL-52 12.080* 8.15 Profit of 424 on sale
2025-07-31BUY156 9.245* 8.12
2025-06-30SELL-104 8.470* 8.08 Profit of 841 on sale
2025-06-25SELL-52 8.030* 8.08 Profit of 420 on sale
2025-06-20SELL-104 7.770* 8.08 Profit of 840 on sale
2025-05-23BUY52 8.080* 8.08
2025-05-19SELL-52 8.070* 8.08 Profit of 420 on sale
2025-05-15SELL-156 8.150* 8.08 Profit of 1,260 on sale
2025-05-12SELL-52 8.120* 8.08 Profit of 420 on sale
2025-05-09SELL-52 8.000* 8.08 Profit of 420 on sale
2025-04-30SELL-52 8.240* 8.08 Profit of 420 on sale
2025-04-24SELL-104 8.100* 8.07 Profit of 840 on sale
2025-04-17SELL-52 7.750* 8.09 Profit of 421 on sale
2025-04-15SELL-156 7.750* 8.10 Profit of 1,263 on sale
2025-04-14SELL-156 7.730* 8.10 Profit of 1,264 on sale
2025-04-09SELL-208 7.610* 8.12 Profit of 1,689 on sale
2025-04-07SELL-371 7.590* 8.14 Profit of 3,019 on sale
2025-04-04SELL-530 7.810* 8.14 Profit of 4,315 on sale
2025-03-31BUY53 8.040* 8.14
2025-03-19SELL-106 8.370* 8.11 Profit of 860 on sale
2025-03-14SELL-318 8.160* 8.11 Profit of 2,577 on sale
2025-03-13SELL-106 8.110* 8.11 Profit of 859 on sale
2025-03-12SELL-1,802 8.150* 8.10 Profit of 14,604 on sale
2025-03-07SELL-106 8.150* 8.10 Profit of 859 on sale
2025-03-06SELL-159 8.190* 8.10 Profit of 1,288 on sale
2025-03-03SELL-53 7.980* 8.09 Profit of 429 on sale
2025-02-28SELL-318 7.950* 8.09 Profit of 2,574 on sale
2025-02-26SELL-53 7.950* 8.11 Profit of 430 on sale
2025-02-25SELL-159 8.030* 8.11 Profit of 1,289 on sale
2025-02-18BUY265 7.990* 8.13
2025-02-13BUY53 7.970* 8.14
2025-02-12BUY53 7.810* 8.15
2025-02-11BUY159 7.610* 8.16
2025-02-06BUY477 8.090* 8.17
2025-01-27BUY53 8.260* 8.19
2024-12-30BUY265 9.170* 8.15
2024-12-06BUY212 8.930* 8.02
2024-12-05BUY53 8.880* 7.99
2024-12-04BUY265 8.720* 7.96
2024-11-29BUY265 8.860* 7.85
2024-11-27BUY212 8.850* 7.76
2024-11-26BUY53 8.710* 7.72
2024-11-21BUY265 8.770* 7.55
2024-11-20BUY159 8.240* 7.51
2024-11-18BUY636 8.010* 7.44
2024-11-12BUY416 8.380* 7.38
2024-11-08BUY260 8.320* 7.31
2024-11-07BUY780 8.340* 7.23
2024-11-06BUY104 7.520* 7.21
2024-10-31BUY52 7.210* 7.18
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AUPH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19262,74266,850576,37545.6%
2025-09-18212,1103,600464,71645.6%
2025-09-17153,878700457,00633.7%
2025-09-16147,6480475,23431.1%
2025-09-15335,7071,650518,11464.8%
2025-09-12239,4100509,37447.0%
2025-09-11302,6781,8191,000,23030.3%
2025-09-10208,079671645,84832.2%
2025-09-09195,1850518,98937.6%
2025-09-08245,6900444,03555.3%
2025-09-05290,1550687,20942.2%
2025-09-04448,3200976,04145.9%
2025-09-03318,5860885,32536.0%
2025-09-02224,7858602,00437.3%
2025-08-2981,172507229,33935.4%
2025-08-2875,1990311,29224.2%
2025-08-27140,202986333,65642.0%
2025-08-26282,477100694,31240.7%
2025-08-25335,068200655,86951.1%
2025-08-22404,7861,099781,36651.8%
2025-08-21175,2790440,53439.8%
2025-08-20171,8390396,27943.4%
2025-08-19182,1027,439496,84436.7%
2025-08-18422,00427,507928,17145.5%
2025-08-15466,0051,037841,10755.4%
2025-08-14392,69511,9481,075,73536.5%
2025-08-13414,67801,259,94032.9%
2025-08-12190,1071,371853,46822.3%
2025-08-11265,158710884,21830.0%
2025-08-08360,0211,0001,095,05532.9%
2025-08-07398,8333,1751,158,61634.4%
2025-08-06716,8013,4321,642,49643.6%
2025-08-05438,9194971,242,45535.3%
2025-08-04362,3816,3191,997,47018.1%
2025-08-01778,24318,2473,485,27522.3%
2025-07-31748,1857,8612,658,82728.1%
2025-07-30289,7215,968910,40231.8%
2025-07-29253,230256362,08869.9%
2025-07-28141,9290290,48648.9%
2025-07-25171,3560387,48044.2%
2025-07-24152,3170374,17740.7%
2025-07-23264,0531,671844,57231.3%
2025-07-22151,707206381,66039.7%
2025-07-21248,055380396,25762.6%
2025-07-18388,384721695,19155.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.